Nagish, a pioneering startup dedicated to enhancing communication accessibility for deaf and hard-of-hearing individuals using AI technology, has announced a significant milestone with the securing of $16 million in funding. This round includes $11 million from Series A led by Canaan Partners, with additional support from existing investors K5 Global, Tokyo Black, Cardumen Capital, Vertex…
VenoStent, Inc., a leading innovator in medical devices aimed at enhancing outcomes for dialysis patients, has successfully closed its Series A funding round, securing $20 million. This round was highlighted by a significant $4 million investment from Norwest Venture Partners, alongside contributions from Good Growth Capital and IAG Capital Partners. Concurrently, the company has been…
DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a pioneering biopharmaceutical firm renowned for its innovative approach to severe ischemic diseases, has announced a significant milestone today. The company successfully finalized agreements for a private placement offering, securing $11.8 million in gross proceeds from accredited investors. This strategic funding round underscores DiaMedica’s commitment to advancing clinical and product…
London-based healthtech startup Cryogenx has successfully raised £800,000 in funding to advance its groundbreaking portable body cooling device, CGX1. This investment round includes a significant contribution of £150,000 from the British Design Fund, alongside support from existing shareholders, angel investors, and a US-based fund. Founded by Matt Anderson, Cryogenx aims to address the critical need…
Zuub, a trailblazer in dental Revenue Cycle Automation, has marked a significant milestone with the closing of a $9 million Series A funding round. Led by Vertical Venture Partners, with participation from existing investors Bonfire Ventures and MTech Capital, this funding underscores Zuub’s commitment to transforming dental practice operations through advanced artificial intelligence and automation…
Qure.ai Technologies Limited has secured a significant strategic investment from the Merck Global Health Innovation Fund in its latest Series D funding round. This partnership marks a pivotal moment for advancing artificial intelligence (AI) in healthcare, particularly in the realm of medical imaging. Qure.ai, renowned for its groundbreaking AI applications, including early detection tools for…
UroMems, a pioneering global company specializing in mechatronics technology for treating stress urinary incontinence (SUI), has secured $47 million in its Series C financing round, marking a record fundraising achievement for the company. This capital infusion will propel pivotal clinical trials of their groundbreaking UroActive™ System, the world’s first smart automated artificial urinary sphincter (AUS)…
In a significant stride towards revolutionizing therapeutic interventions, medtech innovator CUREOSITY has announced securing an additional €3.8 million in funding, catapulting its total investment to over €8.4 million. Specializing in the development of virtual reality (VR) therapy enhanced by gamification, CUREOSITY integrates cutting-edge neuroscientific discoveries, particularly harnessing the power of neuroplasticity, with decades of therapeutic…
EpilepsyGTx, a pioneering biotechnology firm specializing in advanced gene therapies for focal refractory epilepsy, has announced a successful $10 million seed funding round. The financing, spearheaded by the UCL Technology Fund and bolstered by Health Technology Holding, marks a significant milestone in the company’s journey towards combating this challenging neurological disorder. Led by CEO Nicolas…
OCON Therapeutics, a pioneer recognized by the World Economic Forum for its advancements in drug delivery, has announced a significant milestone with the completion of a $10 million investment round led by RH Capital. This funding marks a pivotal moment for OCON as it accelerates efforts to redefine the standard of care in women’s health…
